HOT RELOADING A RUNNING APPLICATION WITH AN UNSAVED SOURCE CODE CHANGE von HASHIMI, Sayed Ibrahim, HIEBERT, William Edwin, LYALIN, Dmitry I, TOUB, Stephen Harris, MATOUSEK, Tomas, EDWARDS, Damian Paul, KRISHNAMOORTHY, Pranav, GARCIA RODOPOULOS, Isadora Sophia

Volltext bestellen

Hot reloading a running application with an unsaved source code change von Matousek, Tomas, Toub, Stephen Harris, Garcia Rodopoulos, Isadora Sophia, Krishnamoorthy, Pranav, Edwards, Damian Paul, Hashimi, Sayed Ibrahim, Hiebert, William Edwin, Lyalin, Dmitry I

Volltext bestellen

Protein O-Mannosyltransferases Affect Sensory Axon Wiring and Dynamic Chirality of Body Posture in the Drosophila Embryo von Baker, Ryan, Nakamura, Naosuke, Chandel, Ishita, Howell, Brooke, Lyalin, Dmitry, Panin, Vladislav M

Volltext

Synergistic activity of PARP inhibition by talazoparib (BMN 673) with temozolomide in pediatric cancer models in the pediatric preclinical testing program von Smith, Malcolm A, Reynolds, C Patrick, Kang, Min H, Kolb, E Anders, Gorlick, Richard, Carol, Hernan, Lock, Richard B, Keir, Stephen T, Maris, John M, Billups, Catherine A, Lyalin, Dmitry, Kurmasheva, Raushan T, Houghton, Peter J

Volltext

Defects in protein O ‐mannosylation result in abnormal muscle contractions and aberrant neural sensory feedback in Drosophila von Panin, Vlad, Baker, Ryan, Nakamura, Nausuke, Lyalin, Dmitry

Volltext

CNTN6 copy number variations: Uncertain clinical significance in individuals with neurodevelopmental disorders von Repnikova, Elena A., Lyalin, Dmitry A., McDonald, Kimberly, Astbury, Caroline, Hansen-Kiss, Emily, Cooley, Linda D., Pfau, Ruthann, Herman, Gail E., Pyatt, Robert E., Hickey, Scott E.

Volltext

Protein O-mannosylation in animal development and physiology: From human disorders to Drosophila phenotypes von Nakamura, Naosuke, Lyalin, Dmitry, Panin, Vladislav M.

Volltext

Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program von Carol, Hernan, Gorlick, Richard, Kolb, E. Anders, Morton, Christopher L., Manesh, Donya Moradi, Keir, Stephen T., Reynolds, C. Patrick, Kang, Min H., Maris, John M., Wozniak, Amy, Hickson, Ian, Lyalin, Dmitry, Kurmasheva, Raushan T., Houghton, Peter J., Smith, Malcolm A., Lock, Richard

Volltext

Initial Testing (Stage 1) of MK-8242-A Novel MDM2 Inhibitor-by the Pediatric Preclinical Testing Program von Kang, Min H., Reynolds, C. Patrick, Kolb, E. Anders, Gorlick, Richard, Carol, Hernan, Lock, Richard, Keir, Stephen T., Maris, John M., Wu, Jianwrong, Lyalin, Dmitry, Kurmasheva, Raushan T., Houghton, Peter J., Smith, Malcolm A.

Volltext

Pharmacodynamic and genomic markers associated with response to the XPO1/CRM1 inhibitor selinexor (KPT-330): A report from the pediatric preclinical testing program von Attiyeh, Edward F., Maris, John M., Lock, Richard, Reynolds, C. Patrick, Kang, Min H., Carol, Hernan, Gorlick, Richard, Kolb, E. Anders, Keir, Stephen T., Wu, Jianrong, Landesman, Yosef, Shacham, Sharon, Lyalin, Dmitry, Kurmasheva, Raushan T., Houghton, Peter J., Smith, Malcolm A.

Volltext

Abstract 1616: Pharmacodynamic and genomic markers associated with response to the XPO1/CRM1 inhibitor selinexor (KPT-330): a report from the Pediatric Preclinical Testing Program von Smith, Malcolm A., Lock, Richard, Carol, Hernan, Maris, John M., Gorlick, Richard, Kolb, E. Anders, Keir, Stephen T., Wu, Jianrong, Landesman, Yosef, Shacham, Sharon, Lyalin, Dmitry, Kurmasheva, Raushan T., Houghton, Peter J.

Volltext

Initial testing (stage 1) of the investigational mTOR kinase inhibitor MLN0128 by the pediatric preclinical testing program von Kang, Min H., Reynolds, C. Patrick, Maris, John M., Gorlick, Richard, Kolb, E. Anders, Lock, Richard, Carol, Hernan, Keir, Stephen T., Wu, Jianrong, Lyalin, Dmitry, Kurmasheva, Raushan T., Houghton, Peter J., Smith, Malcolm A.

Volltext

ACTUATION SYSTEM von VEDERNIKOV, Dmitry, LYALIN, Vladimir

Volltext bestellen